Metropolitan Life Insurance Company (MetLife)’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,590
Closed -$33.7K 736
2024
Q1
$33.7K Buy
4,590
+2,446
+114% +$18K ﹤0.01% 1598
2023
Q4
$8.02K Sell
2,144
-2,381
-53% -$8.91K ﹤0.01% 2242
2023
Q3
$9.59K Hold
4,525
﹤0.01% 2229
2023
Q2
$21.5K Hold
4,525
﹤0.01% 1892
2023
Q1
$25.8K Sell
4,525
-447
-9% -$2.55K ﹤0.01% 1749
2022
Q4
$50.2K Hold
4,972
﹤0.01% 1469
2022
Q3
$111K Hold
4,972
0.01% 950
2022
Q2
$123K Hold
4,972
0.01% 941
2022
Q1
$193K Sell
4,972
-16,007
-76% -$621K 0.01% 837
2021
Q4
$1.23M Sell
20,979
-865
-4% -$50.6K 0.02% 836
2021
Q3
$1.29M Buy
21,844
+238
+1% +$14.1K 0.02% 785
2021
Q2
$1.88M Buy
21,606
+1,363
+7% +$118K 0.03% 558
2021
Q1
$1.67M Buy
20,243
+298
+1% +$24.6K 0.02% 613
2020
Q4
$1.81M Sell
19,945
-828
-4% -$75.3K 0.03% 526
2020
Q3
$830K Buy
20,773
+1,657
+9% +$66.2K 0.01% 852
2020
Q2
$656K Buy
19,116
+686
+4% +$23.5K 0.01% 1022
2020
Q1
$409K Sell
18,430
-1,170
-6% -$26K 0.01% 1172
2019
Q4
$384K Hold
19,600
0.01% 1492
2019
Q3
$304K Sell
19,600
-823
-4% -$12.8K 0.01% 1604
2019
Q2
$415K Hold
20,423
0.01% 1425
2019
Q1
$359K Hold
20,423
0.01% 1509
2018
Q4
$262K Buy
20,423
+3,956
+24% +$50.8K 0.01% 1631
2018
Q3
$268K Hold
16,467
﹤0.01% 1806
2018
Q2
$187K Buy
16,467
+668
+4% +$7.58K ﹤0.01% 1986
2018
Q1
$154K Buy
+15,799
New +$154K ﹤0.01% 2054